Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English


Warning: getimagesize(images/pics/294525-aen-s-dnajp1-positive-results-on.jpg) [function.getimagesize]: failed to open stream: No such file or directory in /var/www/prinsidecom/htdocs/inc/release_details.php on line 330
Business

AEN's dnaJP1 Positive Results on Rheumatoid Arthritis' Treatment. AEN, X-Tra Hot Stock Alert by PennyOmega.com


Print article Print article

2009-11-13 23:45:39 - PennyOmega.com is pleased to announce its X-Tra Hot Stock Alert

***FREE Stock Alerts*** From CRWENEWSWIRE's PennyOmega.com
Click on the link Below:

www.crwenewswire.com/c/pennyomega

__

AEN, Adeona Pharmaceuticals, Inc.

AEN is a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the mature population. Using AEN's proprietary, modified oral zinc delivery technologies, AEN is preparing to initiate the first clinical trial of oral zinc therapy for the once-a-day dietary management of Alzheimer's disease and mild cognitive impairment. AEN is also developing a number of late-stage clinical drug candidates for the treatment of rheumatoid arthritis and multiple sclerosis.

AEN's Oral dnaJP1 is an orally active epitope-specific immunotherapeutic molecule derived from a family of heat shock proteins

that contribute to autoimmune inflammation in rheumatoid arthritis patients.

A Study results of a 160-patient, six-month, double-blind, placebo-controlled Phase 2 clinical trial using AEN's dnaJP1 for the treatment of rheumatoid arthritis shows Positive Results and holds promise for patients with this disease.

AEN is actively seeking worldwide corporate partners interested in assisting in the further development and commercialization of this novel and potentially important new therapeutic approach for rheumatoid arthritis.

__

About PennyOmega.com


PennyOmega.com is a stock watch website, a CRWENewsWire.com Division that provides free daily alerts on stocks. PennyOmega.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. PennyOmega.com also tracks small cap stocks that are on the brink of moving upwards. PennyOmega.com also features companies on its website with research report, analysis, and newsletters.


PennyOmega.com is an independent electronic publication that provides information on selected publicly traded companies. PennyOmega.com is not a registered investment advisor or broker-dealer. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Please do your own Due Diligence before investing in any of the stocks mentioned above. The disclaimer is to be read and fully understood before using our sites, stock alerts, watch list or joining our email list. Full disclaimer can be read at www.PennyOmega.com.


We encourage investors to join the FREE e-mail alerts by visiting:

www.crwenewswire.com/c/pennyomega



About CRWENewswire.com


CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.


***FREE STOCK ALERTS**


Sign up to receive FREE stock alerts from CRWENewswire's PennyOmega.com at www.crwenewswire.com/c/pennyomega


Forward Looking Statement
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.


Author:
Karl Malone
e-mail
Web: www.pennyomega.com
Phone: 7024481543

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser